Back to search

Article

Beyond Cardiology's Pillars: A Network Meta-Analysis Comparing the Recombinant Zoster Vaccine (Shingrix/RZV) with SGLT2 Inhibitors and GLP-1 Receptor Agonists for Prevention of Major Adverse Cardiovascular Events and Dementia in Adults Aged ≥50 Years

2026-05-19

Abstract excerpt

<title>Abstract</title> <p> <bold>Background</bold> Prevention of major adverse cardiovascular events (MACE) and dementia represents the foremost challenge in ageing populations. Two drug classes sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1 RA) are established pillars of cardiometabolic protection in patients with type 2 diabetes mellitus and/or establi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b6ed334e-71d6-5dd0-89ac-6b1d6ccea996
DOI
10.21203/rs.3.rs-9727771/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Beyond Cardiology's Pillars: A Network Meta-Analysis Comparing the Recombinant Zoster Vaccine (Shingrix/RZV) with SGLT2 Inhibitors and GLP-1 Receptor Agonists for Prevention of Major Adverse Cardiovascular Events and Dementia in Adults Aged ≥50 YearsDOI 10.21203/rs.3.rs-9727771/v1
Cardiorenal outcomes of tirzepatide versus semaglutide in adults with type 2 diabetes and chronic kidney disease: a target trial emulation in the TriNetX Global Collaborative NetworkSemantic proximity
Comparative Effectiveness of Second-line Antihyperglycemic Agents for Cardiovascular Outcomes: A Large-scale, Multinational, Federated Analysis of the LEGEND-T2DM StudySemantic proximity
Low-Density Lipoprotein Cholesterol and Dementia Risk: Integrating Mendelian Randomization and Target Trial Emulation Within the Heart–Brain AxisSemantic proximity
Cardiovascular Outcomes of Tirzepatide vs Semaglutide in Obesity Without Type 2 Diabetes: A Matched Cohort StudySemantic proximity
Repurposing drugs for the prevention of vascular dementia: Evidence from drug target Mendelian randomizationSemantic proximity
Metformin Shows Greater Potential Than Semaglutide in Reducing Alzheimer’s Risk in Diabetes Type II via Dual Actions: Tackling Disease Pathways and Environmental Herpesvirus TriggersSemantic proximity
Precision Anti-Inflammatory Therapy in Atherosclerosis: A Systematic Review and Meta-Analysis of Colchicine Timing and Clinical Outcomes in Patients with Atherosclerotic Cardiovascular DiseaseSemantic proximity
Comparative the efficacy and safety of Gosuranemab, Semorinemab, Tilavonemab, and Zagotenemab in patients with Alzheimer's disease: a systematic review and network meta-analysis of randomized controlled trialsSemantic proximity
Tirzepatide cardiovascular benefits and adverse events assessment: a Bayesian network meta-analysisSemantic proximity
Long-term Effectiveness of PCSK9 Inhibitors versus Ezetimibe as Adjunctive Therapy to Statins in Patients with Atherosclerotic Cardiovascular Disease: A TriNetX Database AnalysisSemantic proximity
Effect of SGLT-2 Inhibitors on Cardiovascular Outcomes Among Patients With Heart Failure and Type 2 Diabetes Mellitus: A Systemic Review and Meta-Analysis of Randomized Controlled TrialsSemantic proximity
Developing treatments for cerebral small vessel disease: a scoping review of licensed interventions for potential repurposingSemantic proximity
Select a neighboring publication to make it the new centre.